Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder
Key Research Attributes: GHS-R1a Specificity: Selectively binds to the growth hormone secretagogue receptor without significantly impacting ACTH or cortisol release
Product Specifications BPC-157 Peptide Quality Documentation and Lot Testing HPLC Purity Verification (99%) Purity for each released lot is bounded at 99.0% area integration on a reverse-phase HPLC trace recorded at 220 nm
380 Everolimus, a rapamycin analog with improved pharmacokinetics, similarly reduces -synuclein aggregation in PD models
US$ 27.55
US$ 21.83
US$ 24.53
